Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AIkido Pharma SPEX

AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).


NDAQ:SPEX - Post by User

Bullboard Posts
Comment by Techkimon May 03, 2006 1:44pm
115 Views
Post# 10792790

RE: Obsesity in schools. ALTERNATE SUGAR!

RE: Obsesity in schools. ALTERNATE SUGAR! correction :should read ""Tagatose alternative sugar with the company already 72 million backlog of sales." changed "its" to "company" ------------------------------------------- Regardless of my mis-typing skills and raw english. The company (InfoSpherix Division) has a 72 million backlog of sales. The (BioSpherix Division’s)alternative sugar market is the bonus presently awaiting a bigger entry into the company revenue stream.
Bullboard Posts